NASDAQ IMMY
  • Mark L. Baum, J.D.

    Mark L. Baum, J.D.

    Chief Executive Officer, Member, Board of Directors

    Mark L. Baum is the founder and CEO of Imprimis Pharmaceuticals. He is also the founder and board member of Eton Pharmaceuticals, Surface Pharmaceuticals, and Melt Pharmaceuticals. Read More

  • Andrew R. Boll, CFA, CMA

    Andrew R. Boll, CFA, CMA

    Chief Financial Officer

    Mr. Boll is one of our founding employees at Imprimis. As our Chief Financial Officer and Corporate Secretary, he oversees the Company’s financial and administrative operations including its accounting, financial reporting, investor relations, human resources, legal and other administrative departments. Read More

  • John Saharek

    John Saharek

    Chief Commercial Officer

    Mr. Saharek started with Imprimis in 2013 and is our Chief Commercial Officer. Mr. Saharek oversees all of our commercial activities, including strategic planning, marketing, sales, business development, and market access. Read More

Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.